One shot to stop cancer? HPV vaccine trial tests simpler protection
NCT ID NCT02834637
Summary
This study is testing whether giving girls just one or two doses of the HPV vaccine works as well as the standard three doses to prevent cervical cancer. It involves 930 girls aged 9-14 in Tanzania and will compare their immune responses over several years. The goal is to find a simpler, cheaper way to deliver this life-saving vaccine to more people who need it.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN PAPILLOMA VIRUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mwanza Intervention Trials Unit (MITU)
Mwanza, Tanzania
Conditions
Explore the condition pages connected to this study.